Related Experiment Video
Updated: Apr 15, 2026
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Selection of suitable reference genes for expression analysis in human glioma using RT-qPCR
Susanne Grube1, Tatjana Göttig, Diana Freitag
1Department of Neurosurgery, Section of Experimental Neurooncology, Jena University Hospital, Friedrich-Schiller-University Jena, Erlanger Allee 101, 07747, Jena, Germany, susanne.grube@med.uni-jena.de.
Accurate gene expression analysis in human glioma requires validated reference genes. This study identified Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Ribosomal protein L13a (RPL13A), and Cytochrome c-1 (CYC1) as suitable controls for glioma research.
Area of Science:
- Neuroscience
- Molecular Biology
- Oncology
Background:
- Quantitative real-time reverse-transcription PCR (RT-qPCR) is crucial for human glioma research.
- Expression of reference genes can vary significantly across glioma stages and normal brain tissue.
- Proper selection of endogenous controls is essential for reliable RT-qPCR results.
Purpose of the Study:
- To identify and validate the most suitable reference genes for gene expression studies in human gliomas of varying grades (WHO II-IV).
- To assess the stability of nine candidate reference genes in glioma tissues compared to normal brain.
- To provide guidelines for selecting appropriate reference genes in glioma research.
Main Methods:
- Evaluated nine candidate reference genes: beta-2-microglobulin, CYC1, GAPDH, hydroxymethylbilane synthase, hypoxanthine guanine phosphoribosyl transferase 1, RPL13A, succinate dehydrogenase, TATA-box binding protein, and 14-3-3 protein zeta.
- Utilized geNorm, NormFinder, and BestKeeper algorithms to analyze gene expression stability.
- Compared gene expression levels and variability in glioma tissues versus normal brain.
Main Results:
- GAPDH, RPL13A, and CYC1 were identified as reliable reference genes for normalizing gene expression in glioma.
- These genes are suitable for comparisons between glioma and normal brain, as well as within specific glioma subtypes (anaplastic astrocytoma, glioblastoma).
- While overall expression levels showed no significant differences between glioma and normal brain, stability analyses highlighted a limited number of genes appropriate for normalization across different tumor subgroups.
Conclusions:
- Validated reference genes are critical for accurate gene expression profiling in human glioma.
- GAPDH, RPL13A, and CYC1 are recommended for normalization in glioma RT-qPCR studies.
- Prior validation of reference genes is essential for all gene expression studies in this field.
